Clofazimine in the Treatment of Pulmonary Mycobacterium Avium Complex (MAC) Disease

Authors

Jeremy Hawkins, Oregon Health and Science University - Portland, OR
Sarah Siegel, Oregon Health and Science University - Portland, OR
Emily Henkle, Oregon Health and Science University - Portland, OR
Juzar Ali, LSU Health Sciences Center - New OrleansFollow
William Miller, University of South Florida - Tampa
Pamela J. McShane, University of Texas Health Science Center - Tyler, TX
Julie Philley, University of Texas Health Science Center - Tyler, TX
Charles L. Daley, National Jewish Health - Denver
David E. Griffith, National Jewish Health - Denver
Kevin L. Winthrop, Oregon Health and Science University - Portland, OR

Document Type

Conference Proceeding

Publication Date

5-1-2024

Publication Title

American Journal of Respiratory and Critical Care Medicine

Abstract

American Thoracic Society 2024 International Conference; May 17 - May 22, 2024; San Diego, CA

Volume

209

Comments

C27 NTM/BRONCHIECTASIS RAPID FIRE POSTERS / RAPiD Poster Discussion Session

Recommended Citation

Hawkins, Jeremy; Siegel, Sarah; Henkle, Emily; Ali, Juzar; Miller, William; McShane, Pamela J.; Philley, Julie; Daley, Charles L.; Griffith, David E.; and Winthrop, Kevin L., "Clofazimine in the Treatment of Pulmonary Mycobacterium Avium Complex (MAC) Disease" (2024). School of Medicine Faculty Publications. 3095.
https://digitalscholar.lsuhsc.edu/som_facpubs/3095
10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A5176